Form 8-K Moderna, Inc. For: Oct 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Moderna (MRNA) 'remains comfortable' with Covid vaccine guidance range after Pfizer slashes forecast
October 16, 2023 2:29 PM EDTPharmaceutical company Moderna (NASDAQ: MRNA) released a short statement Monday, aiming to ease worries regarding sales of its Coivd vaccine.
The company's share price dropped Monday after larger rival Pfizer (NYSE: PFE) slashed its 2023 revenue projection by $9 billion late Friday.... More
Moderna (MRNA) remains comfortable with its guided range for FY23 Covid vaccine sales
October 16, 2023 9:03 AM EDT(Updated - October 16, 2023 9:04 AM EDT)
Moderna (NASDAQ: MRNA) disclosed:
On October 16, 2023, Moderna, Inc. (the Company) provided the following statement on the Statements and Perspectives webpage of its Investor Relations... More
